Items by Kinnunen, Hanne
|Up a level|
Kinnunen, H. M. and Mrsny, R. J., 2014. Improving the outcomes of biopharmaceutical delivery via the subcutaneous route by understanding the chemical, physical and physiological properties of the subcutaneous injection site. Journal of Controlled Release, 182 (1), pp. 22-32.
Kinnunen, H., Hebbink, G., Peters, H., Shur, J. and Price, R., 2014. Forthcoming. Defining the Critical Material Attributes of Lactose Monohydrate in Carrier Based Dry Powder Inhaler Formulations Using Artificial Neural Networks. AAPS PharmSciTech
Kinnunen, H., Hebbink, G., Peters, H., Shur, J. and Price, R., 2014. Forthcoming. An Investigation into the Effect of Fine Lactose Particles on the Fluidization Behaviour and Aerosolization Performance of Carrier-Based Dry Powder Inhaler Formulations. AAPS PharmSciTech
Kinnunen, H., Shur, J., Hebbink, G., Muresan, A. S. and Price, R., 2010. Lactose fluidisation properties and their relationship to dry powder inhaler performance. Journal of Pharmacy and Pharmacology, 62 (10), pp. 1342-1343.
Kinnunen, H., 2012. Active sites, agglomerates or increased cohesion? Investigations into the mechanism of how lactose fines improve dry powder inhaler performance. Thesis (Doctor of Philosophy (PhD)). University of Bath.